Latest News

Keep up to date with all that’s happening at Qmx Laboratories; new chemical listings, the latest products and team news.

The Universal Nebulizer for ICP and ICP-MS

The Universal Nebulizer for ICP and ICP-MS

In recent years, the use of inert PFA concentric nebulizers has grown rapidly, due to their greater efficiency, inertness and applicability to microvolume samples. In designing the C-Flow PFA concentric nebulizer, Savillex have used all their PFA molding expertise to make a range of nebulizers more reproducible in performance and more rugged than other PFA nebulizers, and with the C-Flow 700d and 400d/e, they have produced the first truly universal nebulizers – tolerant of very high matrix samples and with a wide sample uptake range, in addition to the usual C-Flow benefits of high sensitivity, ultralow blank, zero dead volume, fast washout and unmatched chemical inertness.

The C-Flow 700d is designed as general purpose nebulizer for ICP-OES replacing standard glass concentric nebulizers whilst the C-Flow 400d is optimised for the lower uptake rates typical of today’s ICP-MS systems.

The C-Flow nebulizers are extremely resistant to clogging by particulates and can be easily and safely backflushed – without the need for tools.

Hassel-free sample introduction for ICP and ICP-MS

  • Robust, rugged and reliable - the ideal nebulizer for routine applications
  • Incredible resistance to salting and clogging
  • Unbeatable sensitivity and matrix compatibility, including HF
  • Compatible with all ICP-OES and ICP-MS instruments
  • Demountable uptake line for easy maintenance

Click here for further information

Please wait…

This item has been added to your basket…

Checkout

Your favourites have been updated…

Veiw favourites

Sorry, we were unable to process this action…

Please check your account details to make sure all the required fields are completed and try again.

Account Settings

Please contact us if the problem persists.

Sorry, there was an issue processing this action…

Please try again later and contact us if the problem persists

Close